Ranked by rounds participated in, from announcements in Sep 26, 2026 – Oct 25, 2026. Lead counts include only confirmed lead roles.
New companies 4 · Follow-on 0
Stages: Series A 1, Series B 1, Series C+ 1, Undisclosed 1
Sharp Performance $18M Series AGeneral Medicine $120M Series BDevoted Health $555M Series GNew companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Coherence Neuro $45M Series ASirona Medical $40M Series DNew companies 0 · Follow-on 2
Stages: Series A 1, Undisclosed 1
Coherence Neuro $45M Series ACoherence Neuro Undisclosed 2024 investment disclosed October 2026New companies 2 · Follow-on 0
Stages: Series A 1, Series C+ 1
Baba $40M Series AAbby Care $82M Series CNew companies 2 · Follow-on 0
Stages: Seed 1, Undisclosed 1
Emerald £1.4M Grant and venture fundingStride £4.6M Seed fundingNew companies 2 · Follow-on 0
Stages: Series B 1, Series C+ 1
Even Healthcare $50M Series BAbby Care $82M Series CNew companies 2 · Follow-on 0
Stages: Series A 1, Undisclosed 1
Quick Undisclosed Capital and business alliance agreementmutex ¥281.6M Series ANew companies 2 · Follow-on 0
Stages: Series B 1, Undisclosed 1
Tiny Health $33M Series BMoneyStack $1M Undisclosed“—” in Led means every role for that investor in this period is undisclosed; it does not mean zero leads. New companies counts the first participation in a company in our records; follow-on counts later participation.